The Role of Radionuclide Diagnostic Methods in Neuro-Oncology
In recent years, positron emission tomography (PET) with amino acid radiopharmaceuticals has assumed increasing importance in the diagnosis of brain tumors and it has already become an additional method of examination along with magnetic resonance imaging (MRI) in many diagnostic centers. The marker...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Luchevaya Diagnostika, LLC
2020-09-01
|
| Series: | Вестник рентгенологии и радиологии |
| Subjects: | |
| Online Access: | https://www.russianradiology.ru/jour/article/view/573 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850065980555788288 |
|---|---|
| author | T. Yu. Skvortsova N. Judov M. Plotkin G. Stoffels N. Galldiks R. N. Krasikova K. J. Langen |
| author_facet | T. Yu. Skvortsova N. Judov M. Plotkin G. Stoffels N. Galldiks R. N. Krasikova K. J. Langen |
| author_sort | T. Yu. Skvortsova |
| collection | DOAJ |
| description | In recent years, positron emission tomography (PET) with amino acid radiopharmaceuticals has assumed increasing importance in the diagnosis of brain tumors and it has already become an additional method of examination along with magnetic resonance imaging (MRI) in many diagnostic centers. The markers of somatostatin receptors seem to be most promising for the PET diagnosis of meningiomas. PET provides important additional information in the diagnosis of brain changes of unknown origin and more accurate information about tumor boundaries, which is necessary for biopsy, neurosurgery, and radiation therapy. In addition, labeled amino acid PET aids in the assessment of disease prognosis, in the differentiation of continued tumor growth from nonspecific therapeutic pathomorphism of the brain, and in the evaluation of treatment efficiency at an earlier time than is possible with MRI. |
| format | Article |
| id | doaj-art-226ffe3a15ef429eae96d31e489ef9cb |
| institution | DOAJ |
| issn | 0042-4676 2619-0478 |
| language | English |
| publishDate | 2020-09-01 |
| publisher | Luchevaya Diagnostika, LLC |
| record_format | Article |
| series | Вестник рентгенологии и радиологии |
| spelling | doaj-art-226ffe3a15ef429eae96d31e489ef9cb2025-08-20T02:48:53ZengLuchevaya Diagnostika, LLCВестник рентгенологии и радиологии0042-46762619-04782020-09-01101422123410.20862/0042-4676-2020-101-4-221-234342The Role of Radionuclide Diagnostic Methods in Neuro-OncologyT. Yu. Skvortsova0N. Judov1M. Plotkin2G. Stoffels3N. Galldiks4R. N. Krasikova5K. J. Langen6Bechtereva Institute of the Human Brain, Russian Academy of Sciences,Institute of Neuroscience and Medicine, Jülich Research Centre; Department of Nuclear Medicine, RWTH University of AachenVivantes Institute of Nuclear MedicineInstitute of Neuroscience and Medicine, Jülich Research CentreInstitute of Neuroscience and Medicine, Jülich Research Centre; Department of Neurology, University of CologneBechtereva Institute of the Human Brain, Russian Academy of SciencesInstitute of Neuroscience and Medicine, Jülich Research Centre; Department of Nuclear Medicine, RWTH University of Aachen; Jülich–Aachen Research Alliance (JARA), Section BrainIn recent years, positron emission tomography (PET) with amino acid radiopharmaceuticals has assumed increasing importance in the diagnosis of brain tumors and it has already become an additional method of examination along with magnetic resonance imaging (MRI) in many diagnostic centers. The markers of somatostatin receptors seem to be most promising for the PET diagnosis of meningiomas. PET provides important additional information in the diagnosis of brain changes of unknown origin and more accurate information about tumor boundaries, which is necessary for biopsy, neurosurgery, and radiation therapy. In addition, labeled amino acid PET aids in the assessment of disease prognosis, in the differentiation of continued tumor growth from nonspecific therapeutic pathomorphism of the brain, and in the evaluation of treatment efficiency at an earlier time than is possible with MRI.https://www.russianradiology.ru/jour/article/view/573reviewpositron emission tomographysingle-photon emission computed tomographybrain tumorsamino acid radiopharmaceuticalso-(2-[18f] fluoroethyl)-l-tyrosine (fet)[68ga]dotatoc |
| spellingShingle | T. Yu. Skvortsova N. Judov M. Plotkin G. Stoffels N. Galldiks R. N. Krasikova K. J. Langen The Role of Radionuclide Diagnostic Methods in Neuro-Oncology Вестник рентгенологии и радиологии review positron emission tomography single-photon emission computed tomography brain tumors amino acid radiopharmaceuticals o-(2-[18f] fluoroethyl)-l-tyrosine (fet) [68ga]dotatoc |
| title | The Role of Radionuclide Diagnostic Methods in Neuro-Oncology |
| title_full | The Role of Radionuclide Diagnostic Methods in Neuro-Oncology |
| title_fullStr | The Role of Radionuclide Diagnostic Methods in Neuro-Oncology |
| title_full_unstemmed | The Role of Radionuclide Diagnostic Methods in Neuro-Oncology |
| title_short | The Role of Radionuclide Diagnostic Methods in Neuro-Oncology |
| title_sort | role of radionuclide diagnostic methods in neuro oncology |
| topic | review positron emission tomography single-photon emission computed tomography brain tumors amino acid radiopharmaceuticals o-(2-[18f] fluoroethyl)-l-tyrosine (fet) [68ga]dotatoc |
| url | https://www.russianradiology.ru/jour/article/view/573 |
| work_keys_str_mv | AT tyuskvortsova theroleofradionuclidediagnosticmethodsinneurooncology AT njudov theroleofradionuclidediagnosticmethodsinneurooncology AT mplotkin theroleofradionuclidediagnosticmethodsinneurooncology AT gstoffels theroleofradionuclidediagnosticmethodsinneurooncology AT ngalldiks theroleofradionuclidediagnosticmethodsinneurooncology AT rnkrasikova theroleofradionuclidediagnosticmethodsinneurooncology AT kjlangen theroleofradionuclidediagnosticmethodsinneurooncology AT tyuskvortsova roleofradionuclidediagnosticmethodsinneurooncology AT njudov roleofradionuclidediagnosticmethodsinneurooncology AT mplotkin roleofradionuclidediagnosticmethodsinneurooncology AT gstoffels roleofradionuclidediagnosticmethodsinneurooncology AT ngalldiks roleofradionuclidediagnosticmethodsinneurooncology AT rnkrasikova roleofradionuclidediagnosticmethodsinneurooncology AT kjlangen roleofradionuclidediagnosticmethodsinneurooncology |